Five-factor prognostic model for survival of post-platinum patients with metastatic urothelial carcinoma receiving PD-L1 inhibitors

PURPOSE: A prognostic model for overall survival (OS) of post-platinum patients with metastatic urothelial carcinoma (mUC) receiving PD-1/PD-L1 inhibitors is necessary since existing models were constructed in the chemotherapy setting. MATERIALS AND METHODS: Patient level data were used from phase I...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Urol
Autors principals: Sonpavde, Guru, Manitz, Juliane, Gao, Chen, Tayama, Darren, Kaiser, Constanze, Hennessy, Daniel, Makari, Doris, Gupta, Ashok, Abdullah, Shaad Essa, Niegisch, Guenter, Rosenberg, Jonathan E., Bajorin, Dean F., Grivas, Petros, Apolo, Andrea B., Dreicer, Robert, Hahn, Noah M., Galsky, Matthew D., Necchi, Andrea, Srinivas, Sandy, Powles, Thomas, Choueiri, Toni K., Pond, Gregory R.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655635/
https://ncbi.nlm.nih.gov/pubmed/32552295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000001199
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars